Abstract

Due to COVID-19, extraordinary measures were put in place for the SAGE meeting of 31 March-2 April 2020. The meeting took place virtually through video conference. 

Documents for each session can be obtained through the Yellow book.

  • Report from IVB director
  • Measles
  • SARS-CoV2 vaccine development
  • Ebola
  • Polio
  • IA2030 Monitoring and Evaluation framework
  • Global Vaccine Safety Blueprint 2.0
  • Meeting report
  • Measles
  • COVID-19
  • Ebola
  • Poliomyelitis